Balance Sheet
Cash Flow Statement
AmortizationCapital ExpendituresCash from Investing ActivitiesCash from OperationsChange in CashExchange Rate EffectFree Cash FlowNet Cash FlowNet Equity Issued and RepurchasedNet Income
Growth Metrics
Income Statement
Others
Ratios

Avricore Health (AVCRF) Net Cash Flow (2016 - 2025)

Historic Net Cash Flow for Avricore Health (AVCRF) over the last 12 years, with Q3 2025 value amounting to -$235135.3.

  • Avricore Health's Net Cash Flow fell 14080.04% to -$235135.3 in Q3 2025 from the same period last year, while for Sep 2025 it was -$425514.0, marking a year-over-year decrease of 14405.53%. This contributed to the annual value of $625125.5 for FY2024, which is 34521.59% up from last year.
  • As of Q3 2025, Avricore Health's Net Cash Flow stood at -$235135.3, which was down 14080.04% from -$298431.0 recorded in Q2 2025.
  • Avricore Health's Net Cash Flow's 5-year high stood at $1.8 million during Q1 2021, with a 5-year trough of -$441164.3 in Q3 2022.
  • Moreover, its 5-year median value for Net Cash Flow was -$79717.1 (2023), whereas its average is $17323.1.
  • As far as peak fluctuations go, Avricore Health's Net Cash Flow skyrocketed by 46703.0% in 2021, and later tumbled by 133565.78% in 2025.
  • Avricore Health's Net Cash Flow (Quarter) stood at -$167766.8 in 2021, then decreased by 9.17% to -$183145.8 in 2022, then skyrocketed by 199.47% to $182167.0 in 2023, then plummeted by 93.12% to $12527.4 in 2024, then tumbled by 1976.97% to -$235135.3 in 2025.
  • Its last three reported values are -$235135.3 in Q3 2025, -$298431.0 for Q2 2025, and $95524.9 during Q1 2025.